Indian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...

Modern Diagnostic and Research Centre's shares are poised for a steady debut on the BSE SME, with grey market premiums indicating a 15% lis...

Union Budget 2026: India's pharmaceutical landscape is on the brink of a transformative boom. To maintain this upward trajectory, the focus...

Molbio Diagnostics, a Goa-based POC diagnostics company, filed its DRHP to raise Rs 200 crore via fresh issue and 1.25 crore shares through...

So, within the generic companies, from the US point of view, Cipla delivered a very good set of results supported by the niche launches. An...

Venture capital fund Lightspeed will lead a $50-60 million investment in Qure.ai through its growth fund. Sources said the VC fund will inv...

The company will invest the proceeds in its subsidiaries to develop medtech products, produce innovative diagnostic solutions, expand its p...

At the Voice of Global South Summit, he also said that India is open to enter into preferential trade agreements with interested countries ...

This is on the back of an aging population, a growing middle class, the rising proportion of lifestyle diseases, an increased emphasis on p...

The scheme can also invest in equities of listed overseas companies, in line with the RBI and SEBI guidelines.

Pick your companies very prudently looking at the earnings growth visibility and the management quality.

The second growth which is coming from in the domestic market is from home diagnostics.

India is a fragmented market and has its own challenges; there is a private sector and public sector. About 80% of the healthcare expenses ...

Cancer Genetics Inc has on Monday announced completing the acquisition of the Hyderabad-based genomic services firm BioServe India which is...

All in all one hopes to see a Pharma friendly budget that can truly unleash the potential of this sector and take India to the next level.

Bangalore-based developer and manufacturer of patient monitoring systems and interventional products, Opto Circuits, acquired US-based Unet...

India's healthcare industry is valued at about $23 billion, which is almost four per cent of the GDP and is expected to grow at 12-13 per c...